Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA.

Area of Science:

• Immunology
• Clinical Chemistry
• Diagnostic Technology

Background:

• Anti-neutrophil cytoplasmic antibodies (ANCA) are key biomarkers for ANCA-associated vasculitis.
• Current diagnostic standards involve indirect immunofluorescence (IIF) for screening and ELISA for confirmation.
• A need exists for more efficient and integrated ANCA testing methods.

Purpose of the Study:

• To evaluate the novel multiplexing CytoBead technology for simultaneous ANCA screening and confirmation.
• To compare the performance of CytoBead technology against conventional IIF and ELISA methods.
• To assess the diagnostic accuracy and efficiency of this new approach.

Main Methods:

• Tested sera from 592 individuals, including patients with vasculitis and other conditions, using classical IIF/ELISA and the automated CytoBead technology.
• CytoBead technology utilized cell- and microbead-based digital IIF for simultaneous testing.
• Compared results for cytoplasmic ANCA (C-ANCA), perinuclear ANCA (P-ANCA), and ANCA against proteinase 3 (PR3) and myeloperoxidase (MPO).

Main Results:

• Good to very good agreement was observed between CytoBead technology and classical methods for all ANCA types (κ values ranging from 0.720 to 0.876).
• No significant differences were found between the methods for PR3-ANCA, P-ANCA, and C-ANCA.
• Automated endpoint ANCA titer detection showed excellent agreement (κ = 0.985) with classical methods.

Conclusions:

• Multiplexing CytoBead technology provides a reliable method for simultaneous ANCA screening and confirmation.
• This novel technique offers a fast, cost-effective, and automated solution for ANCA analysis.
• CytoBead technology represents a significant advancement in the diagnosis of ANCA-associated vasculitis.